Relationships Between Inflammatory Markers and Kynurenine Metabolites in Patients With Schizophrenia but Not Healthy Controls

被引：0
|
作者：
Goldsmith, David [1 ]
Massa, Nicholas [1 ,2 ]
Pearce, Bradley [3 ]
Wommack, Evanthia [1 ]
Alrohaibani, Alaaeddin [2 ]
Goel, Neha [2 ]
Cuthbert, Bruce [1 ,2 ]
Fargotstein, Molly [2 ]
Barr, Dana Boyd [3 ]
Panuwet, Parinya [3 ]
Miller, Andrew [1 ]
Duncan, Erica [1 ,2 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] Atlanta VA Med Ctr, Atlanta, GA USA
[3] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
来源：
BIOLOGICAL PSYCHIATRY | 2019年 / 85卷 / 10期
关键词：
Schizophrenia; Inflammation; Inflammatory Cytokines; Kynurenine;
D O I：
10.1016/j.biopsych.2019.03.927
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
S176
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [1] Inflammatory Markers are Associated With Psychomotor Speed in Patients With Schizophrenia Compared to Healthy Controls
    Goldsmith, David
    Massa, Nicholas
    Pearce, Bradley
    Wommack, Evanthia
    Alrohaibani, Alaaeddin
    Goel, Neha
    Cuthbert, Bruce
    Fargotstein, Molly
    Weng, Lei
    Miller, Andrew
    Duncan, Erica
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S342 - S343
  • [2] Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls
    Hope, Sigrun
    Hoseth, Eva
    Dieset, Ingrid
    Morch, Ragni H.
    Aas, Monica
    Aukrust, Pal
    Djurovic, Srdjan
    Melle, Ingrid
    Ueland, Torill
    Agartz, Ingrid
    Ueland, Thor
    Westlye, Lars T.
    Andreassen, Ole A.
    SCHIZOPHRENIA RESEARCH, 2015, 165 (2-3) : 188 - 194
  • [3] Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls
    Groven, Nina
    Reitan, Solveig Klaebo
    Fors, Egil Andreas
    Guzey, Ismail Cuneyt
    PSYCHONEUROENDOCRINOLOGY, 2021, 131
  • [4] Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls
    Michalczyk, Anna
    Tyburski, Ernest
    Podwalski, Piotr
    Waszczuk, Katarzyna
    Rudkowski, Krzysztof
    Kucharska-Mazur, Jolanta
    Mak, Monika
    Rek-Owodzin, Katarzyna
    Plichta, Piotr
    Bielecki, Maksymilian
    Andrusewicz, Wojciech
    Cecerska-Heryc, Elzbieta
    Samochowiec, Agnieszka
    Misiak, Blazej
    Sagan, Leszek
    Samochowiec, Jerzy
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 116
  • [5] KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING
    Mackay, Gillian M.
    Forrest, Caroline M.
    Christofides, John
    Bridel, Michala A.
    Mitchell, Susan
    Cowlard, Richard
    Stone, Trevor W.
    Darlington, L. Gail
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (04) : 425 - 435
  • [6] Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls
    Zhang, Zhaohua
    Zhang, Minling
    Luo, Yayan
    Ni, Xiaojia
    Lu, Haoyang
    Wen, Yuguan
    Fan, Ni
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2020, 35 (04)
  • [7] Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls
    Radant, AD
    Claypoole, K
    Wingerson, DK
    Cowley, DS
    RoyByrne, PP
    BIOLOGICAL PSYCHIATRY, 1997, 42 (09) : 797 - 805
  • [8] Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study
    Guan, Xiaoni
    Xu, Jing
    Xiu, Meihong
    Li, Xirong
    Liu, Haixia
    Wu, Fengchun
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (10) : 1539 - 1546
  • [9] Evaluation of Simple Markers of Inflammation and Systemic Immune Inflammation Index in Schizophrenia, Bipolar Disorder Patients and Healthy Controls
    Inaltekin, Ali
    Yagci, Ibrahim
    TURK PSIKIYATRI DERGISI, 2023, 34 (01) : 11 - 15
  • [10] The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy
    Wang, Yu
    Fang, Xinyu
    Wang, Guangfa
    Tang, Wei
    Liu, Shasha
    Yang, Yujing
    Chen, Jin
    Ling, Yuru
    Zhou, Chao
    Zhang, Xiangrong
    Zhang, Caiyi
    Su, Kuan-Pin
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 113 : 1 - 11
12345